These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 25576684)
1. Key role of phosphodiesterase 4A (PDE4A) in autophagy triggered by yessotoxin. Fernández-Araujo A; Alfonso A; Vieytes MR; Botana LM Toxicology; 2015 Mar; 329():60-72. PubMed ID: 25576684 [TBL] [Abstract][Full Text] [Related]
2. Role of AKAP 149-PKA-PDE4A complex in cell survival and cell differentiation processes. Fernández-Araujo A; Tobío A; Alfonso A; Botana LM Int J Biochem Cell Biol; 2014 Aug; 53():89-101. PubMed ID: 24813785 [TBL] [Abstract][Full Text] [Related]
3. Yessotoxin activates cell death pathways independent of Protein Kinase C in K-562 human leukemic cell line. Fernández-Araujo A; Alfonso A; Vieytes MR; Botana LM Toxicol In Vitro; 2015 Oct; 29(7):1545-54. PubMed ID: 26025416 [TBL] [Abstract][Full Text] [Related]
4. Different toxic effects of YTX in tumor K-562 and lymphoblastoid cell lines. Fernández-Araujo A; Sánchez JA; Alfonso A; Vieytes MR; Botana LM Front Pharmacol; 2015; 6():124. PubMed ID: 26136685 [TBL] [Abstract][Full Text] [Related]
5. Autophagic activity in BC3H1 cells exposed to yessotoxin. Korsnes MS; Kolstad H; Kleiveland CR; Korsnes R; Ørmen E Toxicol In Vitro; 2016 Apr; 32():166-80. PubMed ID: 26743762 [TBL] [Abstract][Full Text] [Related]
6. In vivo cardiomyocyte response to YTX- and AZA-1-induced damage: autophagy versus apoptosis. Ferreiro SF; Vilariño N; Carrera C; Louzao MC; Santamarina G; Cantalapiedra AG; Cifuentes JM; Crespo A; Botana LM Arch Toxicol; 2017 Apr; 91(4):1859-1870. PubMed ID: 27709272 [TBL] [Abstract][Full Text] [Related]
7. Role of yessotoxin in calcium and cAMP-crosstalks in primary and K-562 human lymphocytes: the effect is mediated by anchor kinase A mitochondrial proteins. Tobío A; Fernández-Araujo A; Alfonso A; Botana LM J Cell Biochem; 2012 Dec; 113(12):3752-61. PubMed ID: 22807343 [TBL] [Abstract][Full Text] [Related]
8. Yessotoxin induces ER-stress followed by autophagic cell death in glioma cells mediated by mTOR and BNIP3. Rubiolo JA; López-Alonso H; Martínez P; Millán A; Cagide E; Vieytes MR; Vega FV; Botana LM Cell Signal; 2014 Feb; 26(2):419-32. PubMed ID: 24511615 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the mammalian target of rapamycin promotes cyclic AMP-induced differentiation of NG108-15 cells. Chin TY; Kao CH; Wang HY; Huang WP; Ma KH; Chueh SH Autophagy; 2010 Nov; 6(8):1139-56. PubMed ID: 20935515 [TBL] [Abstract][Full Text] [Related]
13. Yessotoxin, a Promising Therapeutic Tool. Alfonso A; Vieytes MR; Botana LM Mar Drugs; 2016 Jan; 14(2):. PubMed ID: 26828502 [TBL] [Abstract][Full Text] [Related]
14. Baicalein induces autophagic cell death through AMPK/ULK1 activation and downregulation of mTORC1 complex components in human cancer cells. Aryal P; Kim K; Park PH; Ham S; Cho J; Song K FEBS J; 2014 Oct; 281(20):4644-58. PubMed ID: 25132405 [TBL] [Abstract][Full Text] [Related]
15. [Molecular mechanism of emodin on inhibiting autophagy induced by HBSS in renal tubular cells]. Hu H; Sun W; Gu LB; Tu Y; Liu H Zhongguo Zhong Yao Za Zhi; 2015 May; 40(10):1965-70. PubMed ID: 26390657 [TBL] [Abstract][Full Text] [Related]
16. Yessotoxin as an apoptotic inducer. Korsnes MS; Espenes A Toxicon; 2011 Jun; 57(7-8):947-58. PubMed ID: 21426912 [TBL] [Abstract][Full Text] [Related]
17. Cardiac glycosides induce autophagy in human non-small cell lung cancer cells through regulation of dual signaling pathways. Wang Y; Qiu Q; Shen JJ; Li DD; Jiang XJ; Si SY; Shao RG; Wang Z Int J Biochem Cell Biol; 2012 Nov; 44(11):1813-24. PubMed ID: 22750415 [TBL] [Abstract][Full Text] [Related]
18. Malformin A1 promotes cell death through induction of apoptosis, necrosis and autophagy in prostate cancer cells. Liu Y; Wang M; Wang D; Li X; Wang W; Lou H; Yuan H Cancer Chemother Pharmacol; 2016 Jan; 77(1):63-75. PubMed ID: 26645406 [TBL] [Abstract][Full Text] [Related]
19. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway. Kumar D; Shankar S; Srivastava RK Cancer Lett; 2014 Feb; 343(2):179-89. PubMed ID: 24125861 [TBL] [Abstract][Full Text] [Related]
20. The role of mTOR during cisplatin treatment in an in vitro and ex vivo model of cervical cancer. Leisching GR; Loos B; Botha MH; Engelbrecht AM Toxicology; 2015 Sep; 335():72-8. PubMed ID: 26201060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]